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Abstract: In this retrospective analysis of 10,575 patients who used
fentanyl-based intravenous patient-controlled analgesia (IV-PCA) after
surgery, we evaluated difference between young and elderly patients on
their characteristic of adverse effects.
We reviewed the data collected from the patients who were provided
IV-PCA for pain control following elective surgery under either general
or spinal anesthesia between September 2010 and March 2014. Post-
operative pain, incidence of PCA-related adverse effects, and risk
factors for the need of rescue analgesics and antiemetics for post-
operative 48 hours were analyzed.
Pain intensity (numerical rating scale [NRS]) at postoperative 6 to 12
hours (4.68 vs 4.58,P< 0.01) and incidence of nausea or vomiting (23.8%
vs 20.6%, P< 0.001) were higher in young patients, while incidence of
PCA discontinuation (9.9% vs 11.5%, P< 0.01) and sedation (0.1% vs
0.7%, P< 0.001) was higher in elderly patients. Despite larger fentanyl
dose used, a greater proportion of young patients required rescue analge-
sics (53.8% vs 47.9%, P< 0.001) while addition of ketorolac was
effective in reducing postoperative pain. Despite lower incidence of
postoperative nausea and vomiting (PONV), a larger proportion of elderly
patients required rescue antiemetics (10.1% vs 12.2%, P< 0.001) while
addition of ramosetron was effective in reducing PONV.
In conclusion, when fentanyl-based IV-PCA is used for postoperative
pain control, a larger proportion of young patients may require rescue
analgesics while elderly patients may require more rescue antiemetics.
The addition of ketorolac or ramosetron to the PCA of young and elderly
patients can be effective to prevent rescue analgesics or antiemetics use.
(Medicine 94(45):e2008)eon Kim, MD, PhD MD,
an, MD, PhDINTRODUCTION
I ntravenous patient-controlled analgesia (IV-PCA) is one ofthe most commonly used strategies in modern clinical prac-
tice for controlling postoperative pain. It involves continuous
administration of a programmed dose of analgesics, while also
allowing patients to receive additional, need-based doses. It has
played an important role in improving the prognoses of surgery
and anesthesia by decreasing postoperative pain and increasing
patient satisfaction.1,2 However, there have been several reports
on its adverse effects, which include inadequate pain control,
nausea and vomiting, dizziness, and headache.3,4 There have
been several studies examining the risk factors for occurrence of
PCA-related side effects in an attempt to minimize these
adverse effects in susceptible patients.4–6
With the increasing number of older surgical patients, it
has become more important to understand their patterns of
postoperative pain and adverse effects associated with IV-
PCA. Elderly patients may differ from young patients in many
ways, including physical status, preoperative medication use,
and pain intensity.7 They may also experience adverse effects
different from those experienced by young people after
exposure to the same drug or stimulus. In addition, they may
have a decreased cardiac output, reduced renal and hepatic
function, and increased susceptibility to the central nervous
system active medications.8 Many studies of IV-PCA have been
published since it was introduced for the management of post-
operative pain. However, to our best knowledge, there is no
prior study about postoperative pain and PCA-related adverse
effects comparing elderly and young patients using postopera-
tive IV-PCA. Therefore, in this retrospective study, we inves-
tigated and compared the postoperative pain and the incidence
of PCA-related adverse effects in young and elderly patients-PCA, and evaluated the risk factors for
the need of rescue analgesics and antiemetics during a 48-hour
postoperative period.
METHODS
This study was approved by the Institutional Review Board
(approval no: 3-2015-0070) of Gangnam Severance Hospital,
Seoul, Korea and registered at clinical trials. gov
(NCT02448862). All the patient’s identification information
and data were encoded and scrambled in restricted computer
to protect privacy of all subjects. The informed consent was
waved for this medical record review study, under regulation of
the Institutional Review Board.A service team, consisting of 2 special-
spital, has collected multidisciplinary
atients using IV-PCA during a 48-hour
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factors were larger than 10. The estimated odds ratios (ORs)
anesthesia was more commonly administered than spinal
anesthesia. For maintenance of general anesthesia, an inhala-
tional agent (sevoflurane, desflurane, or isoflurane) was morepostoperative period. They evaluated the clinical outcomes,
such as the quality of pain control, the need for additional
rescue analgesics or antiemetics, and the presence of any
adverse effects, including nausea, vomiting, headache, dizzi-
ness, or sedation. Pain intensity scores were measured on a
numerical rating scale (NRS: 0–10, with 0¼ no pain, and
10¼ extreme pain), and the intensity of nausea was graded
on an 11-point verbal rating scale (0¼ no nausea to
10¼ extreme nausea). Rescue drugs were administered accord-
ing to our institutional guidelines. For rescue analgesics, 30 mg
of ketorolac (Keromin; Hana Pharm. Co., Seoul, Korea) or
25 mg of pethidine (Pethidine; Jeil Pharmaceutical Co. Ltd.,
Daegu, Korea) were administered when pain scores were higher
than 4 on the NRS or upon patient request. A rescue antiemetic
was provided when the nausea score was higher than 4, when
retching or vomiting developed, or upon patient request. A
10 mg dose of metoclopramide (Macperan; Dong Wha Pharm.
Co., Ltd., Seoul, Korea) was administered as the first-line rescue
antiemetic; patients with persistent and refractory nausea and
vomiting were given 4 mg of ondansetron (Onseran; Yuhan,
Seoul, Korea) or 0.3 mg of ramosetron (Nasea; Astellas Pharma
Korea, Seoul, Korea).
The patients’ demographic variables were analyzed,
including age, sex, body mass index, American Society of
Anesthesiologists physical status, as well as any history of
smoking, motion sickness, postoperative nausea and vomiting,
hypertension, and diabetes mellitus. Anesthesia- and surgery-
related variables, including duration of anesthesia, type of
anesthesia (general or spinal), and laparoscopy and other oper-
ation types (categorized as abdominal, thoracic, orthopedic,
head and neck, spine, and other) were also analyzed. All the
postoperative variables were recorded at 0 to 6 (including stays
at the postanesthesia care unit), 6 to 12, 12 to 18, 18 to 24, and
24 to 48 hours postoperatively.
We reviewed the data collected from the patients who were
provided IV-PCA for pain control following elective surgery
under either general or spinal anesthesia between September
2010 and March 2014. We used a disposable PCA pump (Ambix
Anaplus; E-Wha Fresenius Kabi Inc, Gyenoggi-do, Korea, or
Accufuser plus; Woo Young Medical, Chungcheong-do, Korea)
with 100 mL of fentanyl diluted with saline for the 48-hour PCA
infusion. The pump was set at an infusion rate of 2 mL/hour, a
bolus dose of 0.5 or 1 mL, and a lockout time of 15 minutes. It
was at the anesthesiologist’s discretion whether an additional
analgesic drug (60–120 mg of ketorolac or 40–160 mg of
nefopam), and an antiemetic drug (4–16 mg of ondansetron,
0.3–0.6 mg of ramosetron, or 0.075–0.15 mg of palonosetron)
would be added to the PCA, as well as the dosage amount. At the
end of the surgery, a 5-hydroxytryptamine receptor 3 antagonist
(4 mg of ondansetron) was administered to the patients, and then
the IV-PCA was initiated. Patients were divided into young
patients group (age 20–39 years) and elderly patients group
(age 70 years). Exclusion criteria were as follows: age less
than 20 years or between 40 and 69 years, postoperative
ventilator support or intensive care, impaired cognitive func-
tion, routine use of analgesic or antiemetic agents due to certain
type of surgery or other illnesses, and incomplete data.
All statistical analyzes were performed using SAS 9.1
software (SAS Institute Inc, Cary, NC). We analyzed the
demographic characteristics and features of anesthesia and
surgery using a t-test for continuous variables and a x2 test
Koh et al(or a Fisher exact test) for categorical variables. We performed
univariate logistic regression analysis to identify significant
predictors of rescue analgesic or antiemetic administration by
2 | www.md-journal.comconsidering the variables listed above. The factors whose P
values were less than 0.05 in the univariate logistic model, or
were considered clinically important, were included in the
multivariate logistic regression analysis. The possibility of
multicollinearity between factors under consideration was
reduced by excluding the factors whose variance inflation
Medicine  Volume 94, Number 45, November 2015with 95% confidence intervals were presented and P values less
than 0.05 were considered statistically significant.
RESULTS
Among the 25,674 patients for whom data were collected,
a total of 10,575 were included in this study (Fig. 1): 6050 in
the young patients group (age 20–39 years) and 4525 in the
elderly patients group (age 70 years).
The flow chart for patient selection is shown in Figure 1.
Patients’ demographic characteristics, and the details of PCA,
anesthesia, and surgery are described in Table 1. There were
more women among young patients than among elderly patients
(61.3% vs 47.9%). The number of patients with a history of
smoking and an American Society of Anesthesiologists physical
status of 3 or 4 were higher in the elderly patients group than in
the young patients group. Regarding past history, there was no
significant difference between the 2 groups in the incidence of
previous postoperative nausea and vomiting (PONV), while
motion sickness showed a higher prevalence among young
patients compared to elderly patients. Our present analysis
showed that background infusion with fentanyl (between
0.11 and 0.93mg/kg/h in the young patients group, and between
0.05 and 0.87mg/kg/h in the elderly patients group) had no
severe adverse effects in either group. The anesthesiologists had
a tendency to use more fentanyl in the IV-PCA for young
patients, compared to elderly patients and the mean standard
deviation (SD) doses of fentanyl used were 17.6 4.0 versus
15.7 4.3mg/kg, respectively (P< 0.001). The proportions of
additional analgesics and antiemetics mixed into the PCA were
16.0% versus 11.9% and 88.0% versus 89.5% in young and
elderly patients, respectively. The duration of anesthesia was
shorter in young patients compared to elderly patients, and the
meanSD durations were 174.1 110.2versus 213.5
105.6 minutes, respectively (P< 0.001). In both groups, generalFIGURE 1. Flow chart indicating both included patients and
exclusion criteria.
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The independent risk factors for the need of rescue antie-
metics were also analyzed using multivariate analysis. Female
sex was identified as an independent risk factor for increased
TABLE 2. Postoperative Numerical Rating Scale for Pain Inten-
sity
Young
Patients
(n¼ 6050)
Elderly
Patients
(n¼ 4525) P Value
0–6 hours 5.70 1.94 5.74 1.9 0.29
6–12 hours 4.68 1.79 4.58 1.8 0.01
12–18 hours 3.91 1.59 3.97 1.63 0.25
18–24 hours 3.33 1.45 3.32 1.46 0.75
TABLE 1. Preoperative Characteristics of Patients Using Fen-
tanyl-Based IV-PCA
Young
patients
(n¼ 6050)
Elderly
patients
(n¼ 4525) P Value
Patient characteristics
Age, years 31.7 5.8 74.8 4.4 <0.001
Number of smokers 425 (7.0%) 599 (13.2%) <0.001
Number of women 3706 (61.3%) 2169 (47.9%) <0.001
BMI, kg/m2 23.4 4.1 23.6 3.3 0.001
ASA physical status <0.001
I 2906 (65.8%) 509 (14.1%)
II 1232 (27.9%) 1901 (52.8%)
III 238 (5.4%) 1043 (29.0%)
IV 43 (1.0%) 146 (4.1%)
Medical history
Previous PONV 45 (0.7%) 33 (0.7%) 0.93
Motion sickness 388 (6.4%) 128 (2.8%) <0.001
Hypertension 223 (3.7%) 1837 (40.6%) <0.001
Diabetes mellitus 86 (1.4%) 790 (17.5%) <0.001
PCA-related conditions
Fentanyl amount, mg/kg 17.6 4.0 15.7 4.3 <0.001
Mixed analgesics 968 (16.0%) 539 (11.9%)
Ketorolac 505 (8.4%) 187 (4.1%) <0.001
Nefopam 463 (7.7%) 352 (7.8%) 0.81
Mixed antiemetics 5324 (88.0%) 4050 (89.5%)
Ondansetron 3182 (52.6%) 1889 (41.8%) <0.001
Ramosetron 2082 (34.4%) 2064 (45.6%) <0.001
Palonosetron 60 (1.0%) 97 (2.1%) <0.001
Anaesthesia-related condition
Duration of anaesthesia: min 174.1 110.2 213.5 105.6 <0.001
Type of anaesthesia <0.001
General 5181 (85.6%) 4044 (89.4%)
Spinal 869 (14.4%) 481 (10.6%) <0.001
Anaesthetic agent
Inhalation 3867 (74.6%) 3244 (80.2%)
Propofol 1314 (25.4%) 800 (19.8%)
Surgery-related condition
Laparoscopy 1027 (17.0%) 1334 (29.5%) <0.001
Site of surgery <0.001
Abdominal 3134 (53.5%) 2263 (52.2%)
Thoracic 514 (8.8%) 463 (10.7%)
Orthopaedic 1062 (18.1%) 862 (19.9%)
Head & neck 221 (3.8%) 23 (0.5%)
Spine 720 (12.3%) 659 (15.2%)
Others 203 (3.5%) 69 (1.6%)
Values are meanSD or numbers (percentage). ASA¼American
TABLE 3. The Incidence of Patient Controlled Analgesia-
Related Complications in Young and Elderly Patients
Young
Patients
(n¼ 6050)
Elderly
Patients
(n¼ 4525) P Value
Nausea, retching,
or vomiting
1437 (23.8%) 931 (20.6%) <0.001
Headache 136 (2.3%) 75 (1.7%) 0.03
Dizziness 595 (9.8%) 293 (6.5%) <0.001
Medicine  Volume 94, Number 45, November 2015 Intravenous Patient-Controlled Analgesia in Elderly Patientsfrequently chosen than propofol in both groups. Nitrous oxide
was not used in any case, and remifentanil was infused intrao-
peratively in most cases of both young (99.1%) and elderly
(99.5%) patients. Laparoscopic surgeries were more commonly
performed in elderly patients than in young patients (29.48% vs
16.98%, P< 0.001), with abdominal surgery the most com-
monly performed surgery type in both groups.
The NRS for pain was higher in young patients at 6 to
12 hours postoperatively compared with elderly patients. There
was no statistically significant difference at other postoperative
time points (Table 2). The proportion of patients who required
Society of Anesthesiologists, BMI¼ body mass index, PONV¼
postoperative nausea and vomiting, PCA¼ patient controlled analgesia.rescue analgesics at least once during the postoperative 48-hour
period was higher in young patients than in elderly patients
(53.8% vs 47.9%, P< 0.001).
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.Young patients showed a higher incidence of nausea and
vomiting, headache, and dizziness, whereas sedation was more
commonly observed in elderly patients (Table 3). However, the
proportion of patients who required rescue antiemetics at least
once during the postoperative 48-hour period was higher in elderly
patients than in young patients (12.2% vs 10.1%, P< 0.001).
Discontinuation of PCA was more frequently observed in the
elderly patients group compared to the young patients group
(11.5% vs 9.9%, P< 0.01). The causes of PCA discontinuation
were mostly nausea (64.6% vs 67.0%) and dizziness (20.6% vs
17.4%) in both young and elderly patients, respectively.
In the multivariate analysis of risk factors for the need of
rescue analgesics, female sex was identified as an independent
risk factor for an increased need for rescue analgesics, regardless
of age group. A history of smoking was identified as an inde-
pendent factor in young patients, but was not associated with the
need for rescue analgesics in elderly patients. The use of ketorolac
as an adjuvant mixed in the PCA was identified as an independent
factor that could lower rescue analgesic requirements in young
patients, but it did not reduce the rescue analgesic requirements in
elderly patients. Spinal anesthesia and laparoscopic surgery were
not associated with the need for rescue analgesics in either group.
When compared with abdominal surgery, thoracic surgery was
identified as an independent risk factor for an increased require-
ment for rescue analgesics in both groups. Orthopedic surgery
was also identified as a risk factor associated with the need for
rescue analgesics in elderly patients, while head and neck surgery
was revealed as a factor for reducing the analgesic requirement in
young patients (Table 4).
24–48 hours 2.83 1.31 2.84 1.32 0.75
Values are meanSD (standard deviation).Sedation 8 (0.1%) 31 (0.7%) <0.001
Values are number (percentage).
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TABLE 4. Factors Associated With Rescue Analgesics Requirements
Young Patients (n¼ 6050) Elderly Patients (n¼ 4525)
Predictors Odds Ratio P Value Odds Ratio P Value
Female sex 1.39 (1.13–1.71) <0.01 1.59 (1.30–1.95) <0.001
Smoking history 1.52 (1.10–2.12) 0.01 0.99 (0.75–1.03) 0.94
Mixed ketorolac 0.67 (0.51–0.87) <0.01 1.03 (0.64–1.64) 0.91
Type of anesthesia
General Ref Ref
Spinal 1.39 (0.74–2.61) 0.31 1.41 (0.92–2.14) 0.11
Laparoscopy 1.14 (0.86–1.52) 0.36 0.91(0.80–1.03) 0.13
Type of surgery
Abdominal Ref Ref
Thoracic 1.54 (1.11–2.13) 0.01 2.10 (1.51–2.91) <0.001
Orthopedic 1.02 (0.81–1.30) 0.85 1.50 (1.14–1.98) <0.01
Head and neck 0.61 (0.41–0.91) 0.02 0.73 (0.18–2.96) 0.66
Spine 0.97 (0.48–1.93) 0.92 1.31 (0.86–1.99) 0.21
Others 0.56 (0.37–0.83) <0.01 1.12 (0.56–2.13) 0.74
Koh et al Medicine  Volume 94, Number 45, November 2015rescue antiemetic requirement in both groups. The additional
use of ramosetron as an antiemetic agent in the PCA was a
statistically significant independent factor that could lower the
rescue antiemetic requirement in elderly patients but not in
young patients. In young patients, spinal anesthesia was an
independent factor for reduced antiemetic requirements,
whereas laparoscopic surgery was a risk factor for increased
rescue antiemetic requirements. Regarding the type of surgery,
head and neck surgery was identified as a risk factor for the need
of rescue antiemetics in young patients, and orthopedic and
spine surgery were identified as risk factors for the need of
rescue antiemetics in both groups (Table 5).
DISCUSSION
Values are number (95% confidence interval).As elderly patients constitute a large and rapidly increasing
proportion of surgical patients, proper management of postopera-
tive pain that minimizes adverse effects is necessary. However,
TABLE 5. Factors Associated With Rescue Antiemetic Requiremen
Young Patients (n¼ 6050)
Predictors Odds Ratio P
Female sex 1.76 (1.30–2.44) <
Mixed ramosetron
Type of anesthesia
General Ref
Spinal 0.57 (0.37–0.89)
Laparoscopy 2.04 (1.41–2.95) <
Type of surgery
Abdominal Ref
Thoracic 0.97 (0.58–1.61)
Orthopedic 2.94 (1.97–4.39) <
Head and neck 3.09 (1.81–5.29) <
Spine 4.44 (1.95–10.10) <
Other 2.23 (1.25–3.99) <
Values are number (95% confidence interval).
4 | www.md-journal.comthere have been few investigations of the efficacy and adverse
effects of postoperative opioid-based IV-PCA in elderly patients.
We evaluated and compared the postoperative pain and PCA-
related adverse effects in young and elderly patients, and identified
the risk factors for the need of rescue analgesics and antiemetics.
We found that despite the use of larger doses of fentanyl, a greater
proportion of young patients required rescue analgesics than
elderly patients and mixing of ketorolac as an adjuvant in PCA
was an independent factor that could lower rescue analgesic
requirements in young patients. The incidence of the need for
rescue antiemetics and discontinuation of PCA was higher in the
elderly patients while incidence of nausea or vomiting was higher
in young patients. Ramosetron, as an antiemetic agent mixed into
the PCA, was also identified as an independent factor that could
lower the need for rescue antiemetics.
Fentanyl is well suited for IV-PCA because of its rapid
onset time. It is mostly metabolized in the liver into norfentanyl,
t
Elderly Patients (n¼ 4525)
Value Odds Ratio P Value
0.001 1.56 (1.06–2.30) 0.02
0.63 (0.46–0.86) <0.01
Ref
0.01
0.001
Ref
0.90 0.70 (0.40–1.22) 0.21
0.001 1.80 (1.27–2.55) <0.01
0.001 5.58 (0.86–36.33) 0.07
0.001 2.80 (1.68–4.67) <0.001
0.01 0.64 (0.19–2.14) 0.46
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
hydroxy-propionyl-fentanyl, and hydroxypropionyl-norfenta-
nyl (the inactive forms of fentanyl); less than 10% of fentanyl
is excreted through the kidneys without being metabolized.9 In
elderly patients, impaired metabolism of fentanyl due to
decreased hepatic blood flow and function can lead to higher
plasma concentrations of fentanyl as compared to those in
young patients. The brains of elderly patients seem to be more
sensitive to fentanyl, as a study by Scott and Stanski10 found,
which indicated that the amount of fentanyl required to produce
the same electroencephalographic stage decreases with
increased age. Similar to our findings, most clinicians tend
to reduce the dose of fentanyl in IV-PCA for elderly patients on
the assumption of age-related differences between young and
old patients in the pharmacokinetics and pharmacodynamics of
fentanyl. The NRS scores for pain during all postoperative
periods were similar between the 2 groups, except that the
NRS scores at 6 to 12 hours postoperatively were significantly
lower in elderly patients. However, this difference did not seem
to be relevant from the clinical point of view. Despite com-
parable NRSs for postoperative pain, a smaller proportion of
elderly patients required rescue analgesics than young patients.
One of the possible reasons could be that a high proportion of
elderly patients suffer from chronic pain and thus have a
tendency to see pain as a normal part of the aging process,
although they usually have well-preserved pain sensation.11
Several studies have suggested that elderly patients may not
seek help, and regard pain as ‘‘something that I must live
with,’’9,12,13 thereby reporting lower pain intensities than
younger patients.14,15
Sex has been considered as an important factor related to
pain intensity, that is, higher pain intensity is associated with the
female sex. In our study, female sex was identified as an
independent risk factor for the need of rescue analgesics in
both groups, a finding consistent with previous studies.16,17 The
mechanism for a relationship between sex and postoperative
pain control is multidimensional and includes the influence of
neurobiological, psychological, and cognitive factors.18
A decrease in the requirement for rescue analgesics was
observed when ketorolac was mixed into the IV-PCA in the
young patients group. Ketorolac has been used in combination
with opioids in multiple studies,19–21 as it reduces the opioid
requirement dose and its side effects. In the elderly patients in
our study, however, the ketorolac added into the PCA did not
reduce the requirement for rescue analgesics. This finding
might result from the relatively lower dose of ketorolac used
in that group compared to the young patients group, as most
anesthesiologists would not be willing to administer a high dose
of nonsteroidal antiinflammatory drugs to elderly patients, for
fear of its adverse effects. The risk and severity of these adverse
effects, such as gastric bleeding and renal impairment, are
increasing, especially in elderly patients.22,23 Nefopam also
could be considered as an adjuvant to the analgesics added
into IV-PCA, but it did not help reduce the need for rescue
analgesics in either group. Although nefopam might reduce
postoperative fentanyl consumption with better analgesia, its
effect as an adjuvant to opioid analgesia is still controversial,
and further investigation with larger dose of nefopam than ours
may be needed.24,25
Among the type of surgery, thoracic, compared to abdomi-
nal, surgery was identified as an independent risk factor for the
need of rescue analgesics in both groups. The reason for this
Medicine  Volume 94, Number 45, November 2015result might be the large incision and resection performed
during the operation, and hence more aggressive interventions,
including additional peripheral nerve blocks or epidural
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.analgesia, could be considered for better management of
postoperative pain.
After surgery and anesthesia, nausea or vomiting is often
described as a more uncomfortable adverse effect thanpain.26,27
The incidence of nausea or vomiting was higher in young
patients than in elderly patients, which is consistent with
previous findings.28,29 According to the report of Belleville
et al,30 the likelihood of PONV decreases by 13% for each 10-
year increase in age. Therefore, the management of PONV in
elderly patients may often be overlooked, as they are considered
a low-risk group for PONV. However, we found that a larger
proportion of elderly patients than young patients required
rescue antiemetics. In addition, nausea was the main cause
of PCA discontinuation, which was also more common in
elderly patients compared to young patients. This finding might
be related to the report that found that increased age was an
independent factor that increased willingness to pay for PONV
treatment.27 Considering that improper management of PONV
in elderly patients can lead to a failure of IV-PCA as a pain
management modality, and elderly patients may tend to be more
stoic and less willing to spontaneously express discomfort,31 we
should not underestimate the occurrence of PONV in elderly
patients. According to our results, ramosetron can be considered
a more effective antiemetic drug than ondansetron and palo-
nosetron when combined in IV-PCA for elderly patients,
although prospective randomized controlled studies will help
to confirm our results.
Female sex was also a risk factor for increased nausea or
vomiting in both groups, similar to the results of other stu-
dies.4,28,30,32,36,40 Sex-based differences with respect to the
development of PONV may be attributed to variations in serum
gonadotropin or other hormone levels, and thus these differ-
ences may not be significant in preadolescent age groups or in
patients older than 80 years.32–35 In our results, the female sex
in even elderly patients was an independent risk factor for
rescue antiemetic requirement, while its OR (OR: 1.56) was
relatively lower than that of young patients (OR: 1.76). It is
unclear why elderly female patients still showed a high need for
antiemetics, but one possible cause might be that our elderly
patients were mostly in their 70s, and thus could potentially still
be partially influenced by the hormonal variations associated
with the female sex. According to the results of our study, the
use of spinal anesthesia was related to decreased requirement
for rescue antiemetics in young patients. In addition, the type of
surgery could be regarded as a significant predictor of PONV,
although that is still debatable. Orthopedic surgery was related
to increased requirement of rescue antiemetics in both groups,
and laparoscopic surgery, head and neck surgery (including ear,
nose, and throat), and dental surgery were risk factors for the
need of rescue antiemetics in young patients, similar to previous
reports.28,32,36,37 However, it was an unexpected finding that
spine surgery was a potent risk factor for rescue antiemetics in
both groups. One of the possible causes for this finding might be
that in our institution, many cases of multilevel spine surgery
have been performed that required long surgical times and
blood transfusions.
We used a balloon-type PCA device with background
infusion; however, its effectiveness and risk factors are still
being debated. Although the use of background infusion with
morphine is not recommended for elderly patients because of
the increased risk of respiratory depression, some studies have
Intravenous Patient-Controlled Analgesia in Elderly Patientsfound otherwise.38,39 In our institution, fentanyl was used in the
IV-PCA regimen instead of morphine. This was because it has
no active metabolites and displays a wider therapeutic index
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with fewer opioid-related adverse events than morphine, while
there are few reports about background infusion of IV-PCA
using fentanyl.4,5,40 In our results, respiratory depression was
not observed in any patient in either group. For early detection
of respiratory depression, monitoring the presence of sedation
can be a useful indicator. The overall incidence of sedation in
both groups was lower compared to other findings while seda-
tion was more frequently observed in the elderly patients
compared to the young patients as expected.41 These results
suggest that background infusion with fentanyl in the dose range
used in our study is relatively safe, without the risk of respir-
atory depression, even in elderly patients.
This retrospective study has several limitations. In this
study, we did not control either the methods or the drugs used
during anesthesia, or the type and dosage of adjuvant drugs
added to the IV-PCA. However, we think that the results of this
study, obtained from multivariate logistic regression, are
reliable because of the large sample size in our study. Another
limitation is that most of the patients analyzed were either
Korean or belonged to another Asian ethnicity, so the results of
our study may differ for other races or ethnicities.
In conclusion, when fentanyl-based IV-PCA is used for
postoperative pain control, a larger proportion of young patients
may require rescue analgesics, despite the use of larger doses of
fentanyl compared to those given to elderly patients and the
addition of ketorolac to the PCA can be effective for the
prevention of rescue analgesic requirement. Elderly patients
are more likely to demand rescue antiemetics, despite their
relatively lower incidence of PONV compared to young patients
and addition of ramosetron as an antiemetic agent into the PCA
should be considered in the case of elderly patients, due to its
better compliance with a fentanyl-based IV-PCA regimen.
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